Literature DB >> 3119592

Characterization of the chicken oocyte receptor for low and very low density lipoproteins.

R George1, D L Barber, W J Schneider.   

Abstract

The chicken oocyte receptor for low and very low density lipoproteins has been identified and characterized. Receptor activity present in octyl-beta-D-glucoside extracts of oocyte membranes was measured by a solid phase filtration assay, and the receptor was visualized by ligand blotting. The protein had an apparent Mr of 95,000 in sodium dodecyl sulfate-polyacrylamide gels under nonreducing conditions and exhibited high affinity for apolipoprotein B-containing lipoproteins, but not for high density lipoproteins or lipoproteins in which lysine residues had been reductively methylated. Binding of lipoproteins was sensitive to EDTA, suramin, and treatment with Pronase. In these aspects, the avian oocyte system was analogous to the mammalian low density lipoprotein receptor in somatic cells. Furthermore, a structural relationship between the mammalian and avian receptors was revealed by immunoblotting: polyclonal antibodies directed against the purified bovine low density lipoprotein receptor reacted selectively with the 95-kDa chicken receptor present in crude oocyte membrane extracts.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3119592

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  A single chicken oocyte plasma membrane protein mediates uptake of very low density lipoprotein and vitellogenin.

Authors:  S Stifani; D L Barber; J Nimpf; W J Schneider
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

2.  Ligand selectivity of 105 kDa and 130 kDa lipoprotein-binding proteins in vascular-smooth-muscle-cell membranes is unique.

Authors:  V N Bochkov; V A Tkachuk; M P Philippova; D V Stambolsky; F R Bühler; T J Resink
Journal:  Biochem J       Date:  1996-07-01       Impact factor: 3.857

3.  The endogenous lectins of the chick blastoderm are present in association with an apolipoprotein in distinct organelles and in the extracellular matrix.

Authors:  Esmond J Sanders; Sara E Zalik; Wolfgang J Schneider; Irene M Ledsham
Journal:  Rouxs Arch Dev Biol       Date:  1990-05

4.  Avian homologs of the mammalian low-density lipoprotein receptor family bind minor receptor group human rhinovirus.

Authors:  M Gruenberger; R Wandl; J Nimpf; T Hiesberger; W J Schneider; E Kuechler; D Blaas
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

5.  Molecular characterization of quail apolipoprotein very-low-density lipoprotein II: disulphide-bond-mediated dimerization is not essential for inhibition of lipoprotein lipase.

Authors:  I MacLachlan; E Steyrer; A Hermetter; J Nimpf; W J Schneider
Journal:  Biochem J       Date:  1996-07-15       Impact factor: 3.857

6.  Cubilin, the endocytic receptor for intrinsic factor-vitamin B(12) complex, mediates high-density lipoprotein holoparticle endocytosis.

Authors:  S M Hammad; S Stefansson; W O Twal; C J Drake; P Fleming; A Remaley; H B Brewer; W S Argraves
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-31       Impact factor: 11.205

7.  Chicken oocyte growth: receptor-mediated yolk deposition.

Authors:  X Shen; E Steyrer; H Retzek; E J Sanders; W J Schneider
Journal:  Cell Tissue Res       Date:  1993-06       Impact factor: 5.249

8.  Lipoprotein receptors in oocyte growth.

Authors:  W J Schneider
Journal:  Clin Investig       Date:  1992-05

9.  Specific postendocytic proteolysis of apolipoprotein B in oocytes does not abolish receptor recognition.

Authors:  J Nimpf; M Radosavljevic; W J Schneider
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

10.  Iron starvation of Bordetella avium stimulates expression of five outer membrane proteins and regulates a gene involved in acquiring iron from serum.

Authors:  T D Connell; A Dickenson; A J Martone; K T Militello; M J Filiatraut; M L Hayman; J Pitula
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.